본문

  1. Home
45 Results:AA:TANAKA Y 0.92 sec.
RSS 
Multilingual
 高度な検索
 新しい到着検索
選択した印刷 Select Export to Excel
11
Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients:Proposal of diagnostic criteria using FGF23 measurement
Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients:Proposal of diagnostic criteria using FGF23 measurement
Endo, I., | Elsevier Inc | 2008 ,
12
Flt-1 tyrosine kinase-deficient homozygous mice result in decreased trabecular bone volume with reduced osteogenic potential
Flt-1 tyrosine kinase-deficient homozygous mice result in decreased trabecular bone volume with reduced osteogenic potential
Otomo, H., | Elsevier Inc | 2007 ,
13
PTH has the potential to rescue disturbed bone growth in achondroplasia
PTH has the potential to rescue disturbed bone growth in achondroplasia
Ueda, K., | Elsevier Inc | 2007 ,
14
Sustained phosphorylation of mutated FGFR3 is a crucial feature of genetic dwarfism and induces apoptosis in the ATDC5 chondrogenic cell line via PLCγ-activated STAT1
Sustained phosphorylation of mutated FGFR3 is a crucial feature of genetic dwarfism and induces apoptosis in the ATDC5 chondrogenic cell line via PLCγ-activated STAT1
Harada, D., | Elsevier Inc | 2007 ,
15
Biphasic change and disuse-mediated regression of canal network structure in cortical bone of growing rats
Biphasic change and disuse-mediated regression of canal network structure in cortical bone of growing rats
Matsumoto, T., | Elsevier Inc | 2007 ,
16
Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia
Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia
Tanaka, M., | Elsevier Inc | 2008 ,
17
Minodronic acid (ONO-5920/YM529) prevents decrease in bone mineral density and bone strength, and improves bone microarchitecture in ovariectomized cynomolgus monkeys
Minodronic acid (ONO-5920/YM529) prevents decrease in bone mineral density and bone strength, and improves bone microarchitecture in ovariectomized cynomolgus monkeys
Mori, H., | Elsevier Inc | 2008 ,
18
Contributions of 25-hydroxyvitamin D, co-morbidities and bone mass to mortality in Japanese postmenopausal women
Contributions of 25-hydroxyvitamin D, co-morbidities and bone mass to mortality in Japanese postmenopausal women
Kuroda, T., | Elsevier Inc | 2009 ,
19
Effects of ONO-5334, a novel orally-active inhibitor of cathepsin K, on bone metabolism
Effects of ONO-5334, a novel orally-active inhibitor of cathepsin K, on bone metabolism
Ochi, Y, | Elsevier Inc | 2011 ,
20
The Fracture and Immobilization Score (FRISC) for risk assessment of osteoporotic fracture and immobilization in postmenopausal women A joint analysis of the Nagano, Miyama, and Taiji Cohorts
The Fracture and Immobilization Score (FRISC) for risk assessment of osteoporotic fracture and immobilization in postmenopausal women A joint analysis of the Nagano, Miyama, and Taiji Cohorts
Tanaka, S., | Elsevier Inc | 2010 ,
처음이전12345이후마지막